Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Depomed Inc (NASDAQ:DEPO)

6.13
Delayed Data
As of 4:00pm ET
 -0.02 / -0.33%
Today’s Change
5.88
Today|||52-Week Range
27.02
-65.98%
Year-to-Date

Today’s Trading

Previous close6.15
Today’s open6.16
Day’s range6.05 - 6.24
Volume1,729,339
Average volume (3 months)1,786,805
Market cap$387.4M
Dividend yield--
Data as of 4:00pm ET, 08/16/2017

Growth & Valuation

Earnings growth (last year)-15.08%
Earnings growth (this year)-30.53%
Earnings growth (next 5 years)+25.00%
Revenue growth (last year)+33.02%
P/E ratioNM
Price/Sales2.42
Price/Book1.52

Competitors

 Today’s
change
Today’s
% change
SVASinovac Biotech Ltd+0.05+0.74%
PGNXProgenics Pharmaceut...+0.24+4.32%
SNNASienna Biopharmaceut...-0.41-2.07%
GTHXG1 Therapeutics Inc-0.45-3.13%
Data as of 4:00pm ET, 08/16/2017

Financials

Last reporting dateAugust 7, 2017
EPS forecast (this quarter)$0.09
Annual revenue (last year)$455.9M
Annual profit (last year)-$88.7M
Net profit margin-19.46%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
President, Chief Executive Officer &
Director
Arthur Joseph Higgins
Chief Financial Officer &
Senior Vice President
August J. Moretti
Corporate headquarters
Newark, California

Forecasts